Navigation Links
New scanning strategy could help develop heart disease treatments
Date:12/12/2011

Patients with life-threatening heart valve disease could be helped with alternative scanning techniques that provide greater insight into the condition.

Researchers from the University of Edinburgh used an imaging technique that could help predict which patients will need open heart surgery to replace their heart valves, and improve treatments to prevent the disease.

The narrowing and hardening of the heart's aortic valve a common condition known as aortic stenosis affects 1 in 20 people over 65 in the UK and is on the increase due to an ageing population. The study, funded by the British Heart Foundation (BHF), trialled the use of positron emission tomography (PET) scans among patients with the condition.

The scans give a much clearer insight into the process that causes aortic stenosis than ultrasound scans, which are currently used for diagnosis. They involve using tracer chemicals, which highlight molecular changes within the body.

Dr Marc Dweck, of the University of Edinburgh's Clinical Research Imaging Centre, said: "Currently the only form of treatment is heart surgery which is not necessarily ideal as the majority of patients are over 65. These scans will help us better understand what is happening to the heart valves, and hopefully help us to halt the processes causing the narrowing. It may also allow us to predict which patients are likely to need an operation and when this might occur."

The scans showed that inflammation, possibly related to fatty deposits, was important in establishing the very early stages of the disease. However, after this initial trigger subsequent narrowing was instead mainly due to the build-up of calcium deposits in the valve.

The use of the PET scans mean that scientists can now analyse what is happening to heart valves earlier in the disease process, when treatments are more likely to be effective. The study has been published in the journal Circulation.

Dr Shannon Amoils, Research Advisor at the BHF, said: "Aortic stenosis is the most common reason for having a heart valve operation in the UK. It would be much better for patients if we could either prevent the condition or treat it with a drug at an early stage. But the fact is that there are currently no medicines for the condition, and no accurate way of predicting how quickly it will progress.

"We're delighted to have been able to fund this study, which has used state-of-the-art imaging technology to reveal clues about the biology underlying aortic stenosis and how it progresses. The researchers have shown that calcification, or 'hardening', of the aortic valve may be the most important process underlying its progressive narrowing. This could explain why attempts to treat patients by targeting the inflammation in the valve have not worked, and it offers hope that a change of strategy targeting the calcification process might prove more successful."


'/>"/>

Contact: Tara Womersley
tara.womersley@ed.ac.uk
44-131-650-9836
University of Edinburgh
Source:Eurekalert

Related biology news :

1. Frequent CT scanning for testicular cancer surveillance associated with secondary malignancies
2. Aware Software and Development Services Enable State-of-the-Art Fingerprint Card Scanning
3. Eureka! Air cargo scanning wins top prize
4. Federal Bureau of Investigation Awards Lockheed Martin Biometric Card Scanning Service Contract
5. Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost
6. Federal Bureau of Investigation Awards Lockheed Martin Biometric Card Scanning Service Contract
7. identiMetrics & BIO-key(R) Provide Biometric Finger Scanning for School Food Service Nationwide
8. New strategy could lead to dose reduction in X-ray imaging
9. Rudolph the red-nosed reindeers cooling strategy revealed
10. Powerful antibody-based strategy suggests a new therapeutic approach to diabetes and obesity
11. BGI develops new strategy to uncover structural variations of human genomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing ...  3D medical LCD display is the latest premium product recently added to the range ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... NC (PRWEB) , ... June 27, 2016 , ... ... just published their findings on what they believe could be a new and ... of the new research. Click here to read it now. , ...
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
Breaking Biology Technology: